Monday, June 15, 2026

Drug Kingpin K·Jeff Arrested in Nigeria Following NIS’s Global Investigation

NIS apprehended K·Jeff, a Nigerian drug trafficking mastermind, expanding operations globally and using romance scams for recruitment.

The Tech Powering Tomorrow’s Cars Is Being Built Quietly by Hyundai Mobis

Hyundai Mobis enhances its global strategy with 50 new mobility technologies, focusing on electrification, autonomous driving, and advanced materials.

US Expert: Kim Jong Un Gained Nuclear Recognition at China’s Victory Day Parade

Kim Jong-un's presence at China's victory celebration alongside Putin and Xi signifies recognition of North Korea as a nuclear power.

Tag: cancer

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

2026 Hyundai Boulder: The Ultimate Off-Road Pickup Truck Concept Revealed!

Hyundai unveils the Boulder, an off-road concept vehicle, at the NY Auto Show, showcasing its commitment to U.S. mid-size pickup market.

Samsung Medical Center Achieves ICHOM Certification: A New Era for Patient-Centered Cancer Care in Korea

Samsung Medical Center's Cancer Hospital is the first in South Korea to receive ICHOM certification for patient-centered care in breast cancer.

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Daejeon University’s Seoul Oriental Hospital Earns “Integrated Cancer Certification” – What This Means for Patients

Daejeon University's Seoul Oriental Hospital gains recognition as a Certified Integrative Cancer Center for its innovative treatment methods.

GIST’s Breakthrough in Gene Diagnosis: A Game-Changer for Cancer and Infectious Disease Testing

GIST unveils a versatile genetic diagnostic platform, enhancing detection across diseases while simplifying design and improving efficiency.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.